🔎 Trials Near Me

Почетна › Dijabetes tipa 2 › Ajdaho

Kliničke studije za Dijabetes tipa 2 u državi Ajdaho

14 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Ajdaho.

Gradovi u državi Ajdaho

Zvanični tekst studije (na engleskom)

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

  • Rocky Mountain Clinical Research, Idaho Falls
Тражи се учесник
Узраст од 2 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07864168

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Elite Clinical Trials - Blackfoot, Blackfoot
  • Family First Clinical Research, Idaho Falls
  • Solaris Clinical Research, Meridian
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Rocky Mountain Clinical Research - Idaho Falls, Idaho Falls
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Elite Clinical Trials, Blackfoot
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

  • Medical Research Partners, Ammon
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 5. 11. 2026. · NCT07668336

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Elite Clinical Trials, Rexburg
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Idaho Falls
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Paradigm Clinical Research - Boise, ID, Boise
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Care Institute- High Desert, Meridian
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Boise
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  • Elite Clinical Trials, Blackfoot
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 11. 9. 2026. · NCT07415954

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Rocky Mountain Diab&Osteo Ctr, Idaho Falls
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • St. Luke's Children's Endocrinology and Diabetes, Boise
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • Rocky Mountain Diabetes, Idaho Falls
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 8. 2026. · NCT07521475

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.